SOD1 and amyotrophic lateral sclerosis: The understanding of SOD1 aggregation kinetics has introduced new possibilities for ALS therapy through the discovery of small molecules that bind and stabilize either (i) the native state of SOD1 or (ii) the intermediate aggregate species (misfolded monomers, low molecular SOD1 aggregates) [6,24,41,60].